Anti-CD137 Cancer Immunotherapy Suppresses Tumor Growth-Response.

Kwon, Byungsuk
Cancer research
2018Mar ; 78 ( 6 ) :1572-1573.
ÀúÀÚ »ó¼¼Á¤º¸
Kwon, Byungsuk - School of Biological Sciences and Biomedical Research Center, University of Ulsan, Ulsan, Republic of Korea. bkwon@ulsan.ac.kr.
ABSTRACT
na
¸µÅ©

ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
It is likely to take more time to obtain a consensus on the genuine function of CD137L signaling in both mice and humans.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
10.1158/0008-5472.CAN-17-3639
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå